2024
A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer
Gittleman J, Cloutier J, Park E, Rasmussen A, Ponzani C, Weinberger A, Ostroff J, Perez G. A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer. Supportive Care In Cancer 2024, 32: 836. PMID: 39611967, DOI: 10.1007/s00520-024-09030-z.Peer-Reviewed Original ResearchConceptsSmoking cessation medicationsCancer care providersCessation medicationsCancer careCare providersContext of cancer careSemi-structured interview guideTobacco treatment trialQualitative study of attitudesIncrease adherence ratesFollow-up surveyTobacco cessationMedication uptakeReport smokingExit interviewsTobacco useInterview guideNVivo 11Medication nonadherenceAdherence ratesInterrater reliabilityQualitative studyPsychological benefitsDecreased riskConclusionThe findings
2013
Clinical experience with exemestane in postmenopausal women at increased risk of breast cancer.
Sorkin M, Lapolt D, Pusztai L, Hofstatter E. Clinical experience with exemestane in postmenopausal women at increased risk of breast cancer. Journal Of Clinical Oncology 2013, 31: 1565-1565. DOI: 10.1200/jco.2013.31.15_suppl.1565.Peer-Reviewed Original ResearchCancer prevention clinicPostmenopausal womenPrevention clinicBreast cancerRetrospective chart reviewPoor patient acceptancePatient acceptance rateRisk of thrombosisCancer chemoprevention agentsBreast atypiaChemoprevention medicationsChemoprevention uptakeChart reviewEligible womenPatient characteristicsPrevention settingMedication uptakeMean ageChemoprevention agentsMedical historyUterine cancerPatient acceptanceFamily historyGeneral populationExemestane
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply